+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global Clinical Trial Supply and Logistics Market for Pharma set to grow to $15bn by 2025” says new Visiongain report

24 April 2020
Pharma

Visiongain has launched a new pharma report Clinical Trial Supply and Logistics Market for Pharma: Forecasts by Type (Clinical Trial Manufacturing (Clinical Trial Packaging, Others), Clinical Trial Logistics and Distribution (Clinical Trial Cold Chain Logistics, Others), Clinical Trial Supply Chain Management), by End Users (CRO’s, Pharma & Biotech, Others (Academics, Research Institutes etc.)) PLUS COVID-19 Impact Analysis.

Demands for increasingly complex and expensive clinical trials have led drug developers to look to external service providers to source clinical trial materials and deliver them to investigator sites. Demand for biological and orphan drugs will be one of the factors that drive the clinical trial supply and logistics market for pharma. Rising need for cold chain logistics will increase demand for new packaging and monitoring technologies that offer lower-cost solutions, including reusable packaging and phase change materials that allow cooling for more-specific temperature ranges.

The lead analyst of the report commented "The outbreak of COVID-19 has impacted the clinical trials industry causing delays to the 336,444 clinical trials listed on the Clinical Trials website. The impact of COVID-19 has shifted the focus of biopharmaceutical companies to developing a vaccine for COVID-19 and thus potentially disrupting clinical trials for other diseases.

As the pandemic increases the demand for more effective pharmaceutical and medical products will rise. This requires clinical trial supply and logistic service providers to work closely with their end users and safeguard against clinical supply disruptions. Visiongain anticipates that this will create new opportunities for the market players in order to utilise on demand warehousing with the outsourced workforce for value addition & order fulfilment."

Leading companies featured in the report include Almac Group, Amatsigroup, Catalent, DHL, FedEx, Fisher Clinical Services, Marken. and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read